- CSR Summary Not Yet Available
- NCT00723528
- Primary Citation
- Data Specification Not Available
Trial Information
Generic NameUstekinumabProduct NameSTELARA®Therapeutic AreaSkin and Connective Tissue DiseasesEnrollment158% Female19.7%% WhiteN/A
Product ClassAntipsoriaticsSponsor Protocol NumberJNS009-JPN-02Data PartnerJohnson & JohnsonCondition StudiedPsoriasisMean/Median Age (Years)46
Supporting Documentation
- Statistical Analysis Plan Available
- Clinical Study Report Available
Additional Information
Please note: individual participant-level data are not available for this trial. Only the statistical analysis plan and full clinical study report are available.
Approved Data Requests Associated with this Trial
- 2022-4894 : Systemic pharmacological treatments for chronic plaque psoriasis: A Systematic Review and an Individual-Patient Data Network Meta-Analysis of RCTs
- 2019-4067 : Evidence-generation for biologics in pediatric studies
- 2015-0339 : Impact of the dose of immunomodulators on pharmacokinetics of biologics: Patient level meta-analysis of randomized controlled trials